CELZ — Creative Medical Technology Holdings Share News
0.000.00%
Last trade - 00:00- $4.88m
- -$3.81m
- $0.01m
Brief: Creative Medical Technology Announces Peer Reviewed Publication Of Positive Results For Stemspine Study
Brief: Creative Medical Technology Receives Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: Creative Medical Technology Holdings Announces Agreement With Greenstone Biosciences Inc For Development Of A Next Generation Ipsc Pipeline For Its Immcelz Immunotherapy Platform
Brief: Creative Medical Technology Files For Resale Of Shares
Brief: Creative Medical Technology Holdings Files For Offering Of Common Stock And Warrants, Size Not Disclosed - SEC Filing
Brief: Creative Medical Technology Announces Progress In Developing A Reproducible Clinical Grade Of The Company's Immcelz® Product
U.S. STOCKS ON THE MOVE-Allego, GameStop, Worthington
Creative Medical surges on positive long-term data for back pain procedure
Brief: Creative Medical Technology Announces Positive Top-Line Results For StemSpine Pilot Study
Brief: Creative Medical Technology Signs Agreement With Cervos To Become Exclusive Distributor Of Marrow Cellution Devices
Brief: Creative Medical Technology Holdings Announces $3.8 Million Private Placement With Institutional Investors
Brief: Creative Medical Technology Holdings Provides Update On Immcelz FDA Application
Brief: Creative Medical Technology Holdings Completes Amniostem™ Preclinical Studies Needed For FDA Application Filing